Peter Hede - Probi AB VP RD
| PROB Stock | SEK 350.00 1.00 0.28% |
Insider
Peter Hede is VP RD of Probi AB
| Phone | 46 4 62 86 89 20 |
| Web | https://www.probi.com |
Probi AB Management Efficiency
The company has return on total asset (ROA) of 0.0211 % which means that it generated a profit of $0.0211 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of 0.0304 %, meaning that it generated $0.0304 on every $100 dollars invested by stockholders. Probi AB's management efficiency ratios could be used to measure how well Probi AB manages its routine affairs as well as how well it operates its assets and liabilities.Similar Executives
| Showing other executives | INSIDER Age | ||
| Petra Jansson | RaySearch Laboratories AB | 50 | |
| Sebastian Heimfors | BioGaia AB | 49 | |
| Simon Ostergaard | CellaVision AB | 52 | |
| Linda Hagglund | BioGaia AB | 50 | |
| Nina Wallander | CellaVision AB | 49 | |
| Maja Nilsson | Biotage AB | N/A | |
| Julien Veyssy | CellaVision AB | 40 | |
| Daniel Forss | Vitrolife AB | 51 | |
| Raffaella Bombarda | Biotage AB | 49 | |
| Urban Strindlov | CellaVision AB | 59 | |
| Olof Nord | Biotage AB | 48 | |
| JonSverre Schanche | Biotage AB | 66 | |
| Peter Kemlin | RaySearch Laboratories AB | 49 | |
| Yve Thorenburg | CellaVision AB | 65 | |
| Angelika Kjelldorff | BioGaia AB | 54 | |
| Kjell Eriksson | RaySearch Laboratories AB | 50 | |
| Thomas MSc | Vitrolife AB | 64 | |
| Eva Nelson | BioGaia AB | N/A | |
| MBA Econ | BioGaia AB | 73 | |
| Fredrik Lofman | RaySearch Laboratories AB | 45 | |
| Claus Bisgaard | Vitrolife AB | 46 | |
Management Performance
| Return On Equity | 0.0304 | |||
| Return On Asset | 0.0211 |
Probi AB Leadership Team
Elected by the shareholders, the Probi AB's board of directors comprises two types of representatives: Probi AB inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Probi. The board's role is to monitor Probi AB's management team and ensure that shareholders' interests are well served. Probi AB's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Probi AB's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Veronica Dong, Head Singapore | ||
| Henrik Lundkvist, Chief Officer | ||
| Andy McShea, Chief Officer | ||
| Basudha BhattaraiJohansson, VP Sustainability | ||
| Tom Ronnlund, Chief Officer | ||
| Niklas Larsson, Lead Affairs | ||
| Magdolna Dimn, Group Controller | ||
| Peter Hede, VP RD | ||
| Shane Judge, VP Marketing |
Probi Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Probi AB a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | 0.0304 | |||
| Return On Asset | 0.0211 | |||
| Profit Margin | 0.07 % | |||
| Operating Margin | 0.08 % | |||
| Current Valuation | 2.15 B | |||
| Shares Outstanding | 11.39 M | |||
| Shares Owned By Insiders | 68.60 % | |||
| Shares Owned By Institutions | 23.77 % | |||
| Price To Earning | 37.39 X | |||
| Price To Book | 1.61 X |
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Probi Stock Analysis
When running Probi AB's price analysis, check to measure Probi AB's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Probi AB is operating at the current time. Most of Probi AB's value examination focuses on studying past and present price action to predict the probability of Probi AB's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Probi AB's price. Additionally, you may evaluate how the addition of Probi AB to your portfolios can decrease your overall portfolio volatility.